Vaxcyte, Inc.PCVXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+58.4%
5Y CAGR+60.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+58.4%/yr
vs +59.9%/yr prior
5Y CAGR
+60.0%/yr
Consistent
Acceleration
-1.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.5x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $923.67M | +62.2% |
| 2024 | $569.55M | +21.7% |
| 2023 | $468.04M | +101.5% |
| 2022 | $232.26M | +124.0% |
| 2021 | $103.67M | +17.6% |
| 2020 | $88.18M | +66.6% |
| 2019 | $52.92M | +48.9% |
| 2018 | $35.53M | +104.2% |
| 2017 | $17.40M | - |